These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 19568367

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma.
    Higashide T, Murotani E, Saito Y, Ohkubo S, Sugiyama K.
    Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):603-10. PubMed ID: 22116499
    [Abstract] [Full Text] [Related]

  • 3. Acute vision loss after intravitreal injection of bevacizumab (avastin) associated with ocular ischemic syndrome.
    Huang ZL, Lin KH, Lee YC, Sheu MM, Tsai RK.
    Ophthalmologica; 2010 Apr; 224(2):86-9. PubMed ID: 19707032
    [Abstract] [Full Text] [Related]

  • 4. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
    Batioğlu F, Astam N, Ozmert E.
    Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection.
    Ishibashi S, Tawara A, Sohma R, Kubota T, Toh N.
    Arch Ophthalmol; 2010 Dec; 128(12):1539-45. PubMed ID: 21149776
    [Abstract] [Full Text] [Related]

  • 8. Intravitreal bevacizumab as an adjunct treatment for neovascular glaucoma.
    Hasanreisoglu M, Weinberger D, Mimouni K, Luski M, Bourla D, Kramer M, Robinson A, Axer-Siegel R.
    Eur J Ophthalmol; 2009 Dec; 19(4):607-12. PubMed ID: 19551676
    [Abstract] [Full Text] [Related]

  • 9. Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma.
    Ghosh S, Singh D, Ruddle JB, Shiu M, Coote MA, Crowston JG.
    Clin Exp Ophthalmol; 2010 May; 38(4):353-7. PubMed ID: 20665941
    [Abstract] [Full Text] [Related]

  • 10. [Effect of Intravitreal Bevacizumab Injection on Iris and Iridocorneal Angle Neovascularization in Neovascular Glaucoma].
    Ishibashi S, Kondo H.
    J UOEH; 2015 Dec 01; 37(4):299-304. PubMed ID: 26667197
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous intravitreal and intracameral injection of bevacizumab (Avastin) in neovascular glaucoma.
    Yuzbasioglu E, Artunay O, Rasier R, Sengul A, Bahcecioglu H.
    J Ocul Pharmacol Ther; 2009 Jun 01; 25(3):259-64. PubMed ID: 19348598
    [Abstract] [Full Text] [Related]

  • 12. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma: a survey on 23 cases throughout 12-month follow-up.
    Costagliola C, Cipollone U, Rinaldi M, della Corte M, Semeraro F, Romano MR.
    Br J Clin Pharmacol; 2008 Nov 01; 66(5):667-73. PubMed ID: 19032174
    [Abstract] [Full Text] [Related]

  • 13. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.
    Yazdani S, Hendi K, Pakravan M.
    J Glaucoma; 2007 Aug 01; 16(5):437-9. PubMed ID: 17700285
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intravitreal bevacizumab for the treatment of neovascular glaucoma associated with central retinal artery occlusion.
    Sagong M, Kim J, Chang W.
    Korean J Ophthalmol; 2009 Sep 01; 23(3):215-8. PubMed ID: 19794952
    [Abstract] [Full Text] [Related]

  • 16. Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma.
    Silva Paula J, Jorge R, Alves Costa R, Rodrigues Mde L, Scott IU.
    Acta Ophthalmol Scand; 2006 Aug 01; 84(4):556-7. PubMed ID: 16879583
    [No Abstract] [Full Text] [Related]

  • 17. [Intravitreal bevacizumab in the treatment of neovascular glaucoma].
    Ouhadj O, Chergui I, Mendil L, Nouri MT.
    J Fr Ophtalmol; 2009 Feb 01; 32(2):112-6. PubMed ID: 20579473
    [Abstract] [Full Text] [Related]

  • 18. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.
    Saito Y, Higashide T, Takeda H, Murotani E, Ohkubo S, Sugiyama K.
    Am J Ophthalmol; 2010 Jun 01; 149(6):964-972.e1. PubMed ID: 20381786
    [Abstract] [Full Text] [Related]

  • 19. Intravitreal bevacizumab for neovascular glaucoma.
    Andrijević-Derk B, Vatavuk Z, Bencić G, Novak-Laus K, Mandić Z.
    Acta Clin Croat; 2008 Sep 01; 47(3):175-9. PubMed ID: 19175068
    [Abstract] [Full Text] [Related]

  • 20. Intravitreal bevacizumab in a patient with neovascular glaucoma.
    Kahook MY, Schuman JS, Noecker RJ.
    Ophthalmic Surg Lasers Imaging; 2006 Sep 01; 37(2):144-6. PubMed ID: 16583637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.